(VIANEWS) – NEDAP (NEDAP.AS), POLARIS MEDIA (POL.OL), ACOMO (ACOMO.AS) are the highest payout ratio stocks on this list.
We have gathered information concerning stocks with the highest payout ratio up until now. The payout ratio in itself isn’t a guarantee of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. NEDAP (NEDAP.AS)
104.53% Payout Ratio
Nedap N.V., together with its subsidiaries, develops and supplies smart technological solutions in the Netherlands, Germany, rest of Europe, North America, and internationally. The company provides software services that allow healthcare professionals to interconnect; hardware and software solutions for vehicle identification systems; and technological solutions for the dairy farming and pig farming industries. It also offers lighting solutions and UV lamp driver technologies; and RFID solutions for retailers. In addition, the company provides access control and security systems for companies and institutions. Further, it offers workforce management software, a cloud-based software for timesheet processing, employee scheduling, and access control. The company was founded in 1929 and is headquartered in Groenlo, the Netherlands.
Earnings Per Share
As for profitability, NEDAP has a trailing twelve months EPS of €3.16.
PE Ratio
NEDAP has a trailing twelve months price to earnings ratio of 18.54. Meaning, the purchaser of the share is investing €18.54 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.16%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.1%, now sitting on 230.56M for the twelve trailing months.
Moving Average
NEDAP’s value is above its 50-day moving average of €57.44 and above its 200-day moving average of €57.15.
Volume
Today’s last reported volume for NEDAP is 5526 which is 64.36% above its average volume of 3362.
Yearly Top and Bottom Value
NEDAP’s stock is valued at €58.60 at 17:10 EST, below its 52-week high of €63.70 and way higher than its 52-week low of €52.60.
More news about NEDAP.
2. POLARIS MEDIA (POL.OL)
81.97% Payout Ratio
Polaris Media ASA operates as a digital media company in Norway and Sweden. The company provides digital advertising services. It also prints corporate and external newspapers, including editorial vouchers, advertising vouchers and newspapers, civil prints, and other magazines/vouchers. In addition, the company distributes newspapers, as well as parcels, mails, and food deliveries. The company is headquartered in Trondheim, Norway.
Earnings Per Share
As for profitability, POLARIS MEDIA has a trailing twelve months EPS of kr1.83.
PE Ratio
POLARIS MEDIA has a trailing twelve months price to earnings ratio of 27.32. Meaning, the purchaser of the share is investing kr27.32 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.83%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 5, 2023, the estimated forward annual dividend rate is 1.5 and the estimated forward annual dividend yield is 3.11%.
Yearly Top and Bottom Value
POLARIS MEDIA’s stock is valued at kr50.00 at 17:10 EST, way below its 52-week high of kr72.80 and higher than its 52-week low of kr47.20.
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.6%, now sitting on 3.66B for the twelve trailing months.
More news about POLARIS MEDIA.
3. ACOMO (ACOMO.AS)
80.65% Payout Ratio
Acomo N.V., together with its subsidiaries, engages in sourcing, trading, processing, packaging, and distributing conventional and organic food ingredients and solutions for the food and beverage industry worldwide. It operates through five segments: Spices and Nuts, Edible Seeds, Organic Ingredients, Tea, and Food Solutions. The Spices and Nuts segment provides tropical products, including pepper, nutmeg, desiccated coconut, shelled and unshelled nuts, dried fruits, dehydrated vegetables, herbs, rice crackers, and snack products. Its Edible Seeds segment trades, processes, and distributes edible seeds, such as poppy, sesame, pumpkin, and flax, as well as sunflower seeds comprising in-kernel and shelled for the snack and retail industries; birdseeds for wildlife; and edible seeds to bakery, spice, and confectionery industries. The Organic Ingredients segment provides a range of organic food products and ingredients in various categories, including cocoa, coffee, fruit and vegetables, edible seeds, nuts and dried fruits, oils, and premium juice products. Its Tea segment trades, processes, and distributes through warehouses and blending facilities; and monitors and analyzes market development, and shares insight to customers to meet traditional consumer preferences, which include novel appetites for specialty tea. The Food Solutions segment produces and supplies culinary and functional ingredients, plant-based solutions, wet and dry blends, and spice mixes to food companies; and provides product development, manufacturing, packaging, distribution, and inventory management services. The company was formerly known as Amsterdam Commodities N.V. and changed its name to Acomo N.V. in June 2022. Acomo N.V. was founded in 1908 and is based in Rotterdam, the Netherlands.
Earnings Per Share
As for profitability, ACOMO has a trailing twelve months EPS of €1.55.
PE Ratio
ACOMO has a trailing twelve months price to earnings ratio of 12.7. Meaning, the purchaser of the share is investing €12.7 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.27%.
More news about ACOMO.
4. UCB (UCB.BR)
78.24% Payout Ratio
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; BIMZELX for treating psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa; and dapirolizumab pegol for systemic lupus erythematosus. In addition, the company is involved in developing rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; zilucoplan to treat myasthenia gravis and immune-mediated necrotizing myopathy; staccato alprazolam to treat tereotypical prolonged seizure; Bepranemab to treat Alzheimer's disease; and UCB0599 to treat Parkinson's disease. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, Otsuka, and doc.ai. It operates in the United States, Japan, Germany, rest of Europe, Spain, France, China, Italy, the United Kingdom, Ireland, Belgium, and internationally. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, UCB has a trailing twelve months EPS of €1.7.
PE Ratio
UCB has a trailing twelve months price to earnings ratio of 48.59. Meaning, the purchaser of the share is investing €48.59 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.7%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 11.8%, now sitting on 5.11B for the twelve trailing months.
More news about UCB.
5. SPAREBANKEN SØR (SOR.OL)
39.74% Payout Ratio
Sparebanken Sør operates as an independent financial institution in Norway. It operates through two segments, Retail Market and Corporate Market. The company is involved in banking, securities trading, and real estate brokerage activities in Agder, Rogaland, Vestfold, and Telemark counties. It also provides leasing, mortgage, and property management services; and sells general insurance, occupational pension, and group life insurance products. The company was founded in 1824 and is headquartered in Kristiansand, Norway. Sparebanken Sør operates as a subsidiary of Sparebankstiftelsen Sparebanken Sør.
Earnings Per Share
As for profitability, SPAREBANKEN SØR has a trailing twelve months EPS of kr14.97.
PE Ratio
SPAREBANKEN SØR has a trailing twelve months price to earnings ratio of 8.45. Meaning, the purchaser of the share is investing kr8.45 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.4%.
More news about SPAREBANKEN SØR.
6. HOME INVEST BE. (HOMI.BR)
30.83% Payout Ratio
Home Invest Belgium S.A. operates as a real estate investment company in Belgium. It primarily invests in residential properties. As of December 31, 2008, the company's real estate portfolio consisted of 992 rental units with a total rentable space of approximately 111,091 square meters. The company was formerly known as Home Invest and changed its name to Home Invest Belgium S.A. in May 1999. Home Invest Belgium S.A. was founded in 1980 and is based in Brussels, Belgium.
Earnings Per Share
As for profitability, HOME INVEST BE. has a trailing twelve months EPS of €3.22.
PE Ratio
HOME INVEST BE. has a trailing twelve months price to earnings ratio of 4.89. Meaning, the purchaser of the share is investing €4.89 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.2%.
Moving Average
HOME INVEST BE.’s value is below its 50-day moving average of €16.57 and way below its 200-day moving average of €19.56.
Revenue Growth
Year-on-year quarterly revenue growth declined by 6.2%, now sitting on 36.6M for the twelve trailing months.
Volume
Today’s last reported volume for HOME INVEST BE. is 3638 which is 67.44% below its average volume of 11175.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 8, 2023, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 6.29%.
More news about HOME INVEST BE..
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
More news about 1.
